Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Vero Naturals Offers Free Green CBD Powder to Any Organization or Brand Interested in Conducting Case Studies on the Effectiveness of CBD and Cannabidiolic Acid

The company hopes the initiative will increase the number of case studies conducted using cannabidiolic acid to help further demonstrate the effectiveness of the powerful compound


News provided by

Vero Naturals

Apr 28, 2020, 09:30 ET

Share this article

Share toX

Share this article

Share toX


SAN DIEGO, April 28, 2020 /PRNewswire-PRWeb/ -- Vero Naturals, an innovative business to business ingredient provider of the world's first Nano green cannabinoids also known as gCBD, has announced it will provide any interested brands or organizations with free gCBD to conduct case studies. The initiative has launched in order to help further demonstrate the effectiveness of CBD and the hemp plant's various helpful compounds, such as cannabidiolic acid (CBDA), which is profoundly present in gCBD.

CBDA is one of the most powerful and effective cannabinoids that is naturally produced in the cannabis plant and has been found to be 1,000 times more potent than CBD in reducing acute nausea. CBD comes from CBDA as it is a precursor for the compound and it is only turned into CBD if the plant is exposed to a chemical process known as decarboxylation. Unfortunately, extraction processes including CO2 that most companies currently utilize decarboxylate the CBDA into CBD. These extraction processes lead to capturing only a portion of the plant's more than 500 compounds thereby rendering them unable to provide the powerful Natural Entourage Effect that is delivered by the original plant. This means, when case studies are conducted using a non-gCBD product, they are not utilizing the plant to its full potential.

Right now, there is minimal research on CBDA and we have the power to change this. When analyzed in a leading lab, Vero Naturals’ gCBD powder showed CBDA as the most potent cannabinoid.

Post this

Vero Naturals' patented Particle Reduction Process does not decarboxylate the cannabinoids nor use chemicals or CO2, to turn the hemp plant into an ultra-fine green powder that houses a multitude of beneficial compounds, including CBDA plus other cannabinoids and terpenes that are typically lost during most extraction processes. The particle reduction process ensures the powder has a maximum bioavailability for increased metabolic absorption and effectiveness. Vero Naturals gCBD is the whole plant in powder form containing Nano sized particles, which is something no other CBD company can offer. It provides the end consumer with more benefits than traditional CBD oil, balm or isolate. Furthermore, the particle reduction process results in the most effective, 100 percent Natural Entourage Effect possible.

"Vero was born to move the cannabis industry forward and through this initiative, I believe we can do just that," said Vero Naturals President and Co-founder, Rory Millikin. "Right now, there is minimal research on CBDA and we have the power to change this. When analyzed in a leading lab, Vero Naturals' gCBD powder showed CBDA as the most potent cannabinoid. Up until Vero's gCBD was recently commercially released, it was very difficult to obtain CBDA in any kind of quantity thus there is an unfortunately low amount of research and trials on this incredible acidic that was discovered by the Godfather of Cannabis, professor Raphael Mechoulam of Hebrew University, Jerusalem. However, each study that has been conducted shows incredibly promising results. We feel confident that by providing those interested in conducting case studies on CBD and/or CBDA with free gCBD, we can make a difference in millions of lives."

Studies have found that CBDA doesn't simply interact with the endocannabinoid system, it works by inhibiting the cyclooxygenase-2 (COX-2) enzyme, which is associated with inflammation. Additional studies found that CBDA might influence serotonin-related 5-hydroxytryptamine (5-HT) receptors, which is an important discovery for cancer patients, individuals with mental health disorders, those prone to epileptic seizures, and more.

Millikin continued, "This is the ideal time for brands to do right by their customers by dedicating time to researching the best quality ingredients that are not only effective but are clean. Additionally, research organizations can utilize our free gCBD to elevate their studies and have the potential to change the world through their findings. This is a unique time we are living in, but one thing that stays constant is the need for impactful discoveries that might lead to amazing products."

Leading CBD expert, Harvard University graduate, author and former United States Army Medic, Dr. Gregory Smith said, "I have utilized gCBD in various case studies and can confidently say that there is nothing else on the market that compares in quality, wholeness, effectiveness and bioavailability. The current studies on CBDA are incredibly promising and if the discoveries hold true, this compound that is found extensively in Vero's gCBD truly can make an impact on many lives."

Vero Naturals Green CBD is currently used in popular consumer brands such as Kopari Beauty which is available at Ulta nationwide and has already seen large success and outstanding feedback from customers that entrust the products and brands to offer them unique products made with real ingredients like Vero Naturals.

Brands interested in partnering with Vero Naturals to create their clinical trial are invited to get in touch with Rory Millikin at [email protected]. Limited quantities of free gCBD are available and the amount will be determined upon consultation. For more information on Vero Naturals please visit http://www.veronaturals.com.

###

About Vero Naturals
Vero Naturals is an ingredient supplier to brands that has created the first B2B green Nano CBD Powder and Liposomes in the market. Vero Naturals has both patents issued and over 20 pending in a multitude of sectors within the cannabis industry. For more information, please visit http://www.veronaturals.com

SOURCE Vero Naturals

Related Links

http://www.veronaturals.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.